Nuvalent, Inc.

Nuvalent, Inc.verified

NUVL

Price:

$67.95

Market Cap:

$4.39B

Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors, which is under Phase I development; and NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, central nervous system-related adverse events, and brain metastases that might limit the use of first-, second-, and third-gener...[Read more]

Industry

Biotechnology

IPO Date

2021-07-29

Stock Exchange

NASDAQ

Ticker

NUVL

The PE Ratio as of May 2024 (TTM) for Nuvalent, Inc. (NUVL) is -28.08

According to Nuvalent, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -28.08. This represents a change of 14.87% compared to the average of -24.45 of the last 4 quarters.

Nuvalent, Inc. (NUVL) Historical PE Ratio (quarterly & annually)

How has NUVL PE Ratio performed in the past?

The mean historical PE Ratio of Nuvalent, Inc. over the last ten years is -42.56. The current -28.08 PE Ratio has changed 6.50% with respect to the historical average. Over the past ten years (40 quarters), NUVL's PE Ratio was at its highest in in the March 2020 quarter at 20.00. The PE Ratio was at its lowest in in the December 2023 quarter at -29.88.

Quarterly (TTM)
Annual

Average

-42.56

Median

-33.95

Minimum

-76.66

Maximum

-19.85

Nuvalent, Inc. (NUVL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Nuvalent, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 68.33%

Maximum Annual PE Ratio = -19.85

Minimum Annual Increase = -68.09%

Minimum Annual PE Ratio = -76.66

Quarterly (TTM)
Annual
YearPE RatioChange
2023-33.9568.33%
2022-20.171.62%
2021-19.85-68.09%
2020-62.20-18.87%

Nuvalent, Inc. (NUVL) Average PE Ratio

How has NUVL PE Ratio performed in the past?

The current PE Ratio of Nuvalent, Inc. (NUVL) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-24.65

5-year avg

-42.56

10-year avg

-42.56

Nuvalent, Inc. (NUVL) PE Ratio vs. Peers

How is NUVL’s PE Ratio compared to its peers?

Nuvalent, Inc.’s PE Ratio is less than DICE Therapeutics, Inc. (0), less than Arcellx, Inc. (-23.17), greater than Vaxcyte, Inc. (-54.17), less than Viridian Therapeutics, Inc. (-17.58), less than Ventyx Biosciences, Inc. (-3.39), less than Cullinan Oncology, Inc. (-1.40), less than Kiniksa Pharmaceuticals, Ltd. (-7.84), less than Replimune Group, Inc. (155.56), less than Ascendis Pharma A/S (-1.49), less than United Therapeutics Corporation (-13.63), less than Cerevel Therapeutics Holdings, Inc. (12.21), less than Travere Therapeutics, Inc. (-16.30), less than Structure Therapeutics Inc. (-2.95), less than null (-17.64),

Build a custom stock screener for Nuvalent, Inc. (NUVL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuvalent, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nuvalent, Inc. (NUVL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nuvalent, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Nuvalent, Inc.'s PE Ratio?

How is the PE Ratio calculated for Nuvalent, Inc. (NUVL)?

What is the highest PE Ratio for Nuvalent, Inc. (NUVL)?

What is the 3-year average PE Ratio for Nuvalent, Inc. (NUVL)?

What is the 5-year average PE Ratio for Nuvalent, Inc. (NUVL)?

How does the current PE Ratio for Nuvalent, Inc. (NUVL) compare to its historical average?